Filter
1517
Filtered Results: 1517
Text search:
controlled
substances
Featured
Recommendations
181
New Publications
287
Language
Document type
No document type
828
Guidelines
286
Studies & Reports
174
Manuals
114
Strategic & Response Plan
48
Training Material
33
Fact sheets
23
Brochures
4
Situation Updates
3
Resource Platforms
2
Infographics
2
Countries / Regions
India
71
Kenya
49
Global
46
South Africa
40
Western and Central Europe
33
Brazil
30
Nigeria
24
Uganda
24
Ethiopia
24
Mozambique
23
Ghana
22
Liberia
19
Ukraine
17
Sierra Leone
17
Tanzania
16
Africa
15
Latin America and the Carribbean
15
Eastern Europe
15
Nepal
14
Myanmar / Burma
14
Russia
13
Angola
13
Zambia
13
Malawi
11
Indonesia
11
Senegal
9
Zimbabwe
9
Guinea-Bissau
9
Germany
9
Eswatini/ Swaziland
9
Rwanda
8
Syria
8
Guinea
8
South–East Asia Region
8
Namibia
8
Burkina Faso
7
Lesotho
6
Philippines
6
Afghanistan
5
USA
5
Bangladesh
5
Tajikistan
4
Colombia
4
Congo, Democratic Republic of
4
West and Central Africa
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Portugal
4
Lebanon
4
Botswana
4
South Sudan
4
North Macedonia
3
Cameroon
3
Canada
3
Morocco
3
Cambodia
3
Asia
3
East and Southern Africa
3
Argentina
3
Sudan
3
Yemen
3
Georgia
3
Mali
3
Iraq
3
Thailand
2
Mexico
2
China
2
Iran
2
Albania
2
Kyrgyzstan
2
Hungary
2
Jordan
2
Jamaica
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
2
Sri Lanka
2
Chad
2
Pakistan
2
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Togo
1
Kazakhstan
1
Chile
1
Singapore
1
Laos
1
Niger
1
Burundi
1
Peru
1
Armenia
1
Venezuela
1
Saudi Arabia
1
Western Pacific Region
1
Paraguay
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Moldova
1
Greece
1
Palestine
1
Central African Republic
1
Poland
1
Authors & Publishers
Publication Years
Category
Countries
458
Clinical Guidelines
130
Public Health
89
Key Resources
68
Women & Child Health
63
Pharmacy & Technologies
31
Capacity Building
19
Toolboxes
Mental Health
352
HIV
110
COVID-19
97
Pharmacy
74
TB
72
Caregiver
57
AMR
52
Planetary Health
37
Rapid Response
35
NCDs
35
NTDs
34
Ebola & Marburg
32
Conflict
20
Specific Hazards
19
Refugee
17
2.0 Rapid Response
17
Malaria
13
Disability
12
Natural Hazards
10
Global Health Education
8
Zika
7
Polio
5
Cholera
3
Social Ethics
2
Health Financing Toolbox
2
В сборнике представлены статьи специалистов в сфере охраны психического здоровья по различным академическим дисциплинам, включая общую медицину, психиатрию, пси...
Cureus 2024 Jan 16;16(1):e52358. doi: 10.7759/cureus.52358
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Interim policy guidance
National Guidelines for Antiretroviral Therapy
recommended
BMC Infectious Diseases volume 23, Article number: 342 (2023).
Tuberculosis (TB) is among the leading causes of death globally. The disease has a huge burden in Namibia, with a case notification rate of at least 442 per 100,000. To date, Namibia is among the countries with the highest global TB bur...
This document is for public health specialists, health emergency responders, clinicians, health facility managers, health and care workers and IPC practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, dental practices, infecti...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages...
Growing emergencies and displacements across the world demand increasingly complex interventions and responses. The World Health Organization (WHO) has developed Malaria control in emergencies: a field manual to provide technical guidance to help partners respond effectively to malaria in emergency ...
Effective surveillance and monitoring of noncommunicable diseases (NCDs) and their risk factors are essential for informing evidence-based public health policies, addressing health inequities, and ensuring progress toward global and regional targets. By tracking trends in NCDs, their modifiable risk...
PHSM are vital in reducing the risk and scale of infectious disease transmission and lowering hospitalization and deaths. Examples include contact tracing, quarantine and isolation, mask use, ventilation, school or workplace measures, mobility restrictions and travel requirements.
While these mea...
Current HIV/AIDS Reports (2022) 19:358–374. https://doi.org/10.1007/s11904-022-00615-z.
MINDSPACE is an acronym developed by the UK's behavioural insights team to summarise nine key influences on human behaviour: Messenger, Incentives, Norms, Default, Salience, Priming, Affect, Commitment, and E...
Adolescents and young adults aged 10-24 remain underserved in the global response against HIV. Combination prevention, treatment and care programmes use a mix of evidence-based interventions to meet the current HIV prevention needs of adolescents and young adults. However, there needs to be a focus ...
This resource was written to support persons who seek to initiate a support group for suicide loss survivors. Suicide bereavement support groups offer a wide range of benefits that can help individuals to navigate the difficult time following a loss. First and foremost, a support group provides a ch...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands...
The primary audience for this guideline includes policy-makers or service providers who are responsible for developing national and local health-care protocols and policies related to care during pregnancy, childbirth and the postnatal period, and those directly providing care to women during pregna...
